Enveda secures 311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at 2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
The round valued the AI biotech at 2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.